advertisement
11.15 Other drugs in relation to glaucoma (64)
Showing records 1 to 25
Display all abstracts in classification 11.15 Other drugs in relation to glaucoma
Search within classification 11.15 Other drugs in relation to glaucoma91792 Efficacy and safety of oral valganciclovir in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure
Wong MOM
British Journal of Ophthalmology 2021; 105: 1666-1671
91521 Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases
Bauters G
Journal Français d'Ophtalmologie 2021; 44: 67-75
91757 Current intravitreal therapy and ocular hypertension: A review
Sudhalkar A
Indian Journal of Ophthalmology 2021; 69: 236-243
91792 Efficacy and safety of oral valganciclovir in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure
Wong MOM
British Journal of Ophthalmology 2021; 105: 1666-1671
91377 Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD
Swaminathan SS
American Journal of Ophthalmology 2021; 226: 206-216
91643 Safety and efficacy of oral Triclofos in the ophthalmic evaluation of children with pediatric glaucoma: An observational study
Sethi S
Indian Journal of Ophthalmology 2021; 69: 83-86
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Inatani M
Advances in Therapy 2021; 38: 1106-1115
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752
91411 Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C
Bedar MS
Ophthalmologe 2021; 118: 1128-1133
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Inatani M
Advances in Therapy 2021; 38: 1116-1129
91411 Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C
Kellner U
Ophthalmologe 2021; 118: 1128-1133
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Higashide T
Advances in Therapy 2021; 38: 1106-1115
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Moore SM
Scientific reports 2020; 10: 21752
91377 Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD
Kunkler AL
American Journal of Ophthalmology 2021; 226: 206-216
91743 Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
Higashide T
Advances in Therapy 2021; 38: 1116-1129
91757 Current intravitreal therapy and ocular hypertension: A review
Bilgic A
Indian Journal of Ophthalmology 2021; 69: 236-243
91521 Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases
Paques M
Journal Français d'Ophtalmologie 2021; 44: 67-75
91792 Efficacy and safety of oral valganciclovir in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure
Yu AHY
British Journal of Ophthalmology 2021; 105: 1666-1671
91643 Safety and efficacy of oral Triclofos in the ophthalmic evaluation of children with pediatric glaucoma: An observational study
Joshi G
Indian Journal of Ophthalmology 2021; 69: 83-86
91521 Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases
Borderie V
Journal Français d'Ophtalmologie 2021; 44: 67-75
91377 Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD
Quan AV
American Journal of Ophthalmology 2021; 226: 206-216
91643 Safety and efficacy of oral Triclofos in the ophthalmic evaluation of children with pediatric glaucoma: An observational study
Bloria SD
Indian Journal of Ophthalmology 2021; 69: 83-86
91757 Current intravitreal therapy and ocular hypertension: A review
Vasavada S
Indian Journal of Ophthalmology 2021; 69: 236-243
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Matsushita K
Advances in Therapy 2021; 38: 1106-1115
